Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Jiang, Xue song ^a,b   Xiao, Jian ping ^a   Zhang, Ye ^a   Xu, Ying jie ^a   Li, Xiang pan ^a   Chen, Xiu jun ^a   Huang, Xiao dong ^a   Yi, Jun lin ^a   Gao, Li ^a   Li, Ye xiong ^a  

^a CANCER HOSPITAL   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

Boost; Brain metastases; Hypofractionated stereotactic radiotherapy (hsrt)

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN METASTASIS; BRAIN RADIATION; CLINICAL ARTICLE; FEMALE; HUMAN; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; LUNG INFECTION; MALE; OVERALL SURVIVAL; RADIATION DOSE; RADIATION NECROSIS; RETROSPECTIVE STUDY; SALVAGE THERAPY; STEREOTACTIC TREATMENT; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME; BRAIN TUMOR; CLINICAL TRIAL; KAPLAN MEIER METHOD; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIOSURGERY; SKULL IRRADIATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RADIOSURGERY;

EID: 84862815216     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-36     Document Type: Article

References (21)

1. Patchell RA. The management of brain metastases. Cancer Treat Rev 2003, 29:533-540. 10.1016/S0305-7372(03)00105-1, 14585263.
2. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672. 10.1016/S0140-6736(04)16250-8, 15158627.
3. Müller-Riemenschneider F, Bockelbrink A, Ernst I, Schwarzbach C, Vauth C, von der Schulenburg JM, Willich SN. Stereotactic radiosurgery for the treatment of brain metastases. Radiother Oncol 2009, 91:67-74. 10.1016/j.radonc.2008.12.001, 19135750.
4. Shiau CY, Sneed KP, Shu HK, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PH, Larson DA. Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997, 37:375-383. 10.1016/S0360-3016(96)00497-X, 9069310.
5. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases:final report of RTOG protocol 90-05[J]. Int J Radiat Oncol Biol Phys 2000, 47:291-298. 10.1016/S0360-3016(99)00507-6, 10802351.
6. Molenaar R, Wiggenraad R. Verbeek-de Kanter A, Walchenbach R, Vecht C: Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 2009, 23:170-178. 10.1080/02688690902755613, 19306173.
7. Tokuuye K, Akine Y, Sumi M, Kagami Y, Ikeda H, Oyama H, Inou Y, Shibui S, Nomura K. Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1998, 40:1151-1155. 10.1016/S0360-3016(97)00954-1, 9539571.
8. Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, Broaddus WC. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:603-608. 10.1016/S0360-3016(00)00475-2, 10837942.
9. Lindvall P, Bergstrom P, Lofroth PO, Henriksson R, Bergenheim AT. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys 2005, 61:1460-1466. 10.1016/j.ijrobp.2004.08.027, 15817351.
10. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 2006, 81:18-24. 10.1016/j.radonc.2006.08.024, 16978720.
11. Narayana A, Chang J, Yenice K, Chan K, Lymberis S, Brennan C, Gutin PH. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg 2007, 85:82-87. 10.1159/000097923, 17167236.
12. Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, Duncan G, Skingley P, Foster G, Levine M. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476. 10.1002/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X, 8839553.
13. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500. 10.1056/NEJM199002223220802, 2405271.
14. Noordijk EM, Vecht CJ, Haaxma-Reiche H, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994, 29:711-717. 10.1016/0360-3016(94)90558-4, 8040016.
15. Yang HC, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D. What factors predict the response of larger brain metastases to radiosurgery?. Neurosurgery 2011, 68:682-690. 10.1227/NEU.0b013e318207a58b, 21311296.
16. Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N, Sawamura Y, Miyasaka K, et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 2003, 56:793-800. 10.1016/S0360-3016(03)00014-2, 12788187.
17. Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer 2009, 115:890-898. 10.1002/cncr.24082, 19132728.
18. Fahrig A, Ganslandt O, Lambrecht U, Grabenbauer G, Kleinert G, Sauer R, Hamm K. Hypofractionated stereotactic radiotherapy for brain metastases-results from three different dose concepts. Strahlenther Onkol 2007, 183:625-630. 10.1007/s00066-007-1714-1, 17960338.
19. Stafinski T, Jhangri GS, Yan E, Menon D. Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and metaanalysis. Cancer Treat Rev 2006, 32:203-213. 10.1016/j.ctrv.2005.12.009, 16472924.
20. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751. 10.1016/S0360-3016(96)00619-0, 9128946.
21. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:1001-1006. 10.1016/S0360-3016(00)00547-2, 10863071.